Recruiting
Methamphetamine Cue-reactivity
NCT07086014
- Conditions
- Methamphetamine Use Disorder
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
Clinical trial condition
Methamphetamine Use Disorder
Explore clinical trials studying Methamphetamine Use Disorder. Study availability and eligibility vary by location and protocol.
40 public trials
11 recruiting studies
Methamphetamine Use Disorder trial results
Not yet recruiting
Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder
NCT07825857
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Methamphetamine Use Disorder, +1 more
- Locations
-
- University of Southern California (USC) Los Angeles, California, United States
- Center of Substance Use and Health San Francisco, California, United States
- Oklahoma State University (OSU) Center for Health Services Tulsa, Oklahoma, United States
- UT Southwestern Medical Center Dallas, Texas, United States
Not yet recruiting
Psilocybin for Methamphetamine Use Disorder
NCT07774702
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Methamphetamine Use Disorder, +1 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
Not yet recruiting
Closed-loop TBS Targeting rPO for the Core Clinical Features of the Methamphetamine Use Disorder
NCT07775807
- Conditions
- Chemically-Induced Disorders, Craving, Cue-reactivity, +4 more
- Locations
-
- Shanghai Mental Health Center, 200030 Shanghai, Shanghai Municipality, China
Not yet recruiting
Closed-loop TMS for the Core Clinical Features of the Methamphetamine Use Disorder
NCT07154160
- Conditions
- Chemically-Induced Disorders, Craving, Cue-reactivity, +4 more
- Locations
-
- Shanghai Mental Health Center, 200030 Shanghai, Shanghai Municipality, China
Not yet recruiting
Psilocybin Therapy for Methamphetamine Use Disorder and HIV
NCT07756736
- Conditions
- Acquired Immunodeficiency Syndrome, Amphetamine-Related Disorders, Blood-Borne Infections, +19 more
- Locations
-
- UCSF at Zuckerberg San Francisco General Hospital San Francisco, California, United States
Not yet recruiting
Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study
NCT07509112
- Conditions
- Behavior, Behavior, Addictive, Chemically-Induced Disorders, +5 more
- Locations
-
- Kirketon Road Centre Darlinghurst, New South Wales, Australia
- Rankin Court Treatment Centre, St Vincent's Hospital Sydney Darlinghurst, New South Wales, Australia
- Alcohol & Drug Service, Metro Health North Brisbane Brisbane, Queensland, Australia
- Drug and Alcohol Services, South Australia Morphett Vale, South Australia, Australia
Not yet recruiting
Methamphetamine Use Disorder Support in Heart Failure Pilot Study
NCT07211724
- Conditions
- Cardiovascular Diseases, Heart Diseases, Heart Failure, +1 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- University of Southern California, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences Los Angeles, California, United States
Enrolling by invitation
An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder
NCT07693608
- Conditions
- Body Weight, Cocaine Use Disorder, Methamphetamine Use Disorder, +8 more
- Locations
-
- UT Southwestern Medical Center Dallas, Texas, United States
Enrolling by invitation
LDART for Stimulant Use Disorder
NCT07221396
- Conditions
- Cocaine Use Disorder, Methamphetamine Use Disorder, Stimulant Use Disorder
- Locations
-
- Yale University New Haven, Connecticut, United States